Curess announces investment by Holland Capital
Amsterdam – CFI is pleased to announce that it acted as the exclusive corporate finance advisor to Curess on its investment by Holland Capital.
About Curess
With over 200 registered professionals, Curess provides specialised ambulatory youth care, including intensive system guidance, ambulatory emergency help, perspective research, and co-parenting investigations. The organisation focuses on strengthening families through practical and directly applicable assistance. Curess operates without waiting lists and can scale its operations up and down quickly, to deliver the desired care swiftly and with high quality. The organisation achieves this by utilising self-developed software that supports core processes, such as planning, and thus reduces administrative pressure. Curess operates in the regions of Twente, Midden-IJssel, Oost-Veluwe, Noord-Veluwe, Achterhoek, and Zuid-Drenthe, in the Netherlands.
About Holland Capital
Holland Capital has been investing in promising Dutch and German SMEs with growth ambitions for over 40 years. The company has offices in Amsterdam, the Netherlands, and Dusseldorf, Germany. With specialised sector teams, Holland Capital focuses on the Healthcare, Technology, and Agrifood-Tech sectors.
About the transaction
This strategic partnership will enable Curess to achieve its ambitious growth and development goals. With Holland Capital’s expertise and resources, Curess is better positioned to enhance its impact on youth care and provide essential support to families. This investment aligns with Holland Capital’s strategy to invest in enterprises addressing societal challenges, marking a significant step in strengthening the company’s portfolio within the healthcare sector.
CFI’s role in the process
Curess and CFI have maintained a strong relationship for over 15 years, founded on trust and successful collaborations. Due to this longstanding partnership, Curess invited CFI to orchestrate the deal. Among other tasks, CFI assisted by conducting market analysis, facilitating negotiations, and managing due diligence. These efforts culminated in a successful transaction, finalised on 29 May 2024.
Eddy de Bruin, CEO of Curess: “We are very grateful for the collaboration with CFI. Their commitment, guidance and ability to maintain clarity throughout the complex process have been of great importance. CFI’s proactive approach to finding and contracting the right growth partner for Curess has proven invaluable every step of the way. With the support of Holland Capital, we can realise our ambitions and help even more young people and families.”
Related
This transaction was advised by:
Our latest transactions
Food & Beverage & Agribusiness
a subsidiary of
has sold its assets to
Transaction details
ISE America, the 17th largest egg producer in the United States and wholly owned by Japanese conglomerate ISE Foods Co., has sold all its assets to Cal-Maine Foods
Transport & Logistics
has been acquired by
and
Transaction details
RPM Freight Systems has been acquired by Trive Capital and Bluejay Capital